Testing effectiveness (Phase 2)Active Not RecruitingNCT06107413
What this trial is testing
Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab
Who this might be right for
Unresectable Metastatic Colorectal Cancer
AbbVie 280